European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

In mice, stress altered the way that the brain packaged memories, resulting in an unnecessary fear response — but drugs were ...

Dementia death rates stable between 2018 and 2019, then increased in 2020, and declined in 2022, with the rate higher than 2018, 2019 ...

If the European Commission decides to grant sales of the medicine, it will be the first Alzheimer's medicine available in the ...

EU drugs regulator recommends approval of Leqembi for early Alzheimer's, pending European Commission acceptance, for specific ...

Alzheimer’s changed the couple’s routine, but not their fight to keep going. Together, David and Pamela are awareness advocates for the Alzheimer’s Association. They’ve met with representatives on ...

The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...

The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at ...